Saskia Middeldorp, MD, qualified as a medical doctor at the University of Amsterdam, The Netherlands, in 1992. She received her training in internal medicine at the Academic Medical Center in Amsterdam and obtained her board licence in 1999 (subspecialty Vascular Medicine, 2002). Dr Middeldorp defended her PhD thesis entitled “Clinical and laboratory studies in hereditary and acquired prothrombotic states” in 2000. Her thesis focused on the clinical implications of thrombophilia and the mechanisms underlying the relationship between oral contraceptives and venous thromboembolism.
Since December 2010, she is professor and co-chair of the Department of Vascular Medicine of the Academic Medical Center in Amsterdam. She leads the residency program of vascular medicine and the clinical thrombosis and hemostasis research lines of the Department.
Her present research focuses on several aspects of hereditary and acquired thrombophilia, women’s issues in thrombosis and hemostasis, and the clinical evaluation of new anticoagulants. Dr Middeldorp is co-author of the Pregnancy chapter of the ACCP guidelines on Antithrombotic management (2012), member of the Dutch national antithrombotic guideline committee and of the American Society of Hematology (ASH) Guideline Coordination Panel (2014-present) She chairs the ASH guideline Thrombophilia chapter and is co-author on the pregnancy chapter (expected publication date 2017). Currently she supervises 10 PhD students.Back to speakers